ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-OR025

Lung Double Negative (αβ+CD4-CD8-) T Cells Respond to AKI and Can Directly Protect from Lung Injury: A Protective Mediator During Kidney-Lung Cross-Talk?

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Bush, Errol L., Johns Hopkins, Baltimore, Maryland, United States
  • Hsu, Joshua, Johns Hopkins University, Baltimore, Maryland, United States
  • Sadasivam, Mohanraj, Johns Hopkins University, Baltimore, Maryland, United States
  • Hamad, Abdel, Johns Hopkins University, Baltimore, Maryland, United States
  • Rabb, Hamid, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Background

Kidney-lung cross talk during AKI contributes to the high mortality and reveals key interactions between lung and kidney. CD4-CD8- (double-negative; DN) αβ T cells have been recently described in kidney and rapidly respond to local ischemia reperfusion injury (IRI) with a protective anti-inflammatory cytokine profile, but the response to remote injury is unknown. We hypothesized that DN T cells serve a potential protective role as an immunologic mediator of kidney-lung crosstalk following remote as well as local injury.

Methods

B6 Wild type (WT) mice were subjected to IRI on either kidney or in lung by a established methods. Lymphocytes from lung was isolated and analysed by flow cytometry. H&E staining was performed with lung tissue to assess lung edema. Immunoblotting with cleaved caspase-3 was evaluated for apoptosis. To test the role for DN T cells in lung IRI, adoptive transfer of DN T cells prior to lung IRI was performed.

Results

Our data show that the frequency of lung DN T cell was significantly increased following both lung (39.1%) and kidney IRI (23.5%), p<0.05, compared to sham (10.7%). Immunoblotting of cleaved caspase-3 revealed higher levels of apoptosis at 3 and 6 hours of both renal and lung IRI. Evans blue extravasation demonstrated that adoptive transfer of DN T cells significantly decreased interstitial thickening and lung permeability (39.5 µg vs. 28 µg, p<0.05). Quantitative analysis of cleaved caspase-3 immunoblotting showed that DN T cell transfer attenuated cellular apoptosis (3.2 vs. 0.8, p<0.01). To assess the human relevance of lung DN T cells, lung samples were studied during implantation of lung transplants which were exposed to ischemia reperfusion, and DN T cells were also found in the human lungs (18.4% at ischemia, 39.2% at reperfusion).

Conclusion

These data demonstrate that DN T cells are a potential immunologic mediator of kidney-lung cross talk, and studies in lung IRI extend the role of DN T cells from kidney IRI to importance in lung injury as well. Further studies are needed to elucidate the mechanism of this potentially immunoregulatory response and human correlates

Funding

  • NIDDK Support